Aldeyra Therapeutics Inc ALDX

NAS: ALDX | ISIN: US01438T1060   14/11/2024
4,270 USD (-3,17%)
(-3,17%)   14/11/2024

6 november 2023 · Thinking about buying stock in Aldeyra Therapeutics, Alphabet Inc., DraftKings, Evelo Biosciences, or Enlivex Therapeutics? · Persbericht

2 november 2023 · Thinking about buying stock in NXU, AERWINS Technologies, Chevron, CASI Pharmaceuticals, or Aldeyra Therapeutics? · Persbericht

20 oktober 2023 · Thinking about buying stock in Momentus Inc, micromobility.com, Aldeyra Therapeutics, Mullen Automotive, or Processa Pharmaceuticals? · Persbericht

17 oktober 2023 · Thinking about buying stock in Momentus Inc, Secoo Holding, RedHill Biopharma, Aldeyra Therapeutics, or Mereo BioPharma Group? · Persbericht

29 september 2023 · SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of a Class Action against Aldeyra Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ALDX · Persbericht

28 september 2023 · SHAREHOLDER ALERT: Levi & Korsinsky Notifies Aldeyra Therapeutics, Inc.(ALDX) Investors of a Class Action Lawsuit and Upcoming Deadline · Persbericht

27 september 2023 · SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Aldeyra Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 29, 2023 - (NASDAQ: ALDX) · Persbericht

26 september 2023 · ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit · Persbericht

26 september 2023 · Final Deadline Alert: ALDX Investor Alert: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Aldeyra Therapeutics, Inc. Class Action Lawsuit · Persbericht

26 september 2023 · SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Aldeyra Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 29, 2023 - (NASDAQ: ALDX) · Persbericht

24 september 2023 · ALDX FINAL DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important September 29 Deadline in Securities Class Action - ALDX · Persbericht

11 september 2023 · ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit · Persbericht

28 augustus 2023 · ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit · Persbericht

22 augustus 2023 · Investors who lost over $100,000 with Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between March 2022 and June 2023 should contact the Shareholders Foundation in connection with Lawsuit · Persbericht

Mijn selecties